tirzepatide fda news Ban on Compounded GLP-1 Drugs: What to Know Is Tirzepatide FDA Approved?

[20] Gastrointestinal complaints head the list of common adverse events: nausea affects roughly one in ten patients, while abdominal cramps and decreased appetite frequently manifest during early weeks but usually diminish with continued therapy or slower titration

Its also worth noting that research on GLP-1s and mental health is still evolving

Although the FDA has approved six drugs for weight management (IMCIVREE, Saxenda, Wegovy, Qsymia, Xenical, and Zepbound), state Medicaid programs arent required to provide coverage for this medical indication

Water helps your kidneys remove excess sugar from your blood through urine

STEP 1 reported nausea in 44% of patients, vomiting in 24%, and diarrhea in 31% on 2.4 mg semaglutide